The osteocyte as a director of bone metabolism

References (9)

1. Pathak JL, Bravenboer N, Klein-Nulend J. The osteocyte as the new discovery of therapeutic options in rare bone diseases. Front Endocrinol (Lausanne) 2020;11:405
2. Bonewald LF. The Role of the osteocyte in bone and nonbone disease. Endocrinol Metab Clin North Am 2017;46:1-18
3. Ru JY, Wang YF. Osteocyte apoptosis: the roles and key molecular mechanisms in resorption-related bone diseases. Cell Death Dis 2020;11:846
4. Yan Y, Wang L, Ge L, Pathak JL. Osteocyte-mediated translation of mechanical stimuli to cellular signaling and its role in bone and non-bone-related clinical complications. Curr Osteoporos Rep 2020;18:67-80
5. Coskun Benlidayi I, Basaran S, Evlice A, Erdem M, Demirkiran M. Prevalence and risk factors of low bone mineral density in patients with multiple sclerosis. Acta Clin Belg 2015;70:188-92
6. Raterman HG, Bultink IE, Lems WF. Osteoporosis in patients with rheumatoid arthritis: an update in epidemiology, pathogenesis, and fracture prevention. Expert Opin Pharmacother 2020;21:1725-37
7. Feng X, McDonald JM. Disorders of bone remodeling. Annu Rev Pathol 2011;6:121-45
8. Robling AG, Bonewald LF. The osteocyte: New insights. Annu Rev Physiol 2020;82:485-506. 9 Divieti Pajevic P, Krause DS. Osteocyte regulation of bone and blood. Bone 2019;119:13-8
9. Coskun Benlidayi I. Denosumab in the treatment of glucocorticoid-induced osteoporosis. Rheumatol Int 2018;38:1975-84